Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy

BACKGROUND: In Study 19, maintenance monotherapy with olaparib significantly prolonged progression-free survival vs placebo in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer. METHODS: Study 19 was a randomised, placebo-controlled, Phase II trial enrolling 265 patients w...

詳細記述

保存先:
書誌詳細
出版年:Br J Cancer
主要な著者: Friedlander, Michael, Matulonis, Ursula, Gourley, Charlie, du Bois, Andreas, Vergote, Ignace, Rustin, Gordon, Scott, Clare, Meier, Werner, Shapira-Frommer, Ronnie, Safra, Tamar, Matei, Daniela, Shirinkin, Vadim, Selle, Frédéric, Fielding, Anitra, Lowe, Elizabeth S., McMurtry, Emma L., Spencer, Stuart, Rowe, Philip, Mann, Helen, Parry, David, Ledermann, Jonathan
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group UK 2018
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6219499/
https://ncbi.nlm.nih.gov/pubmed/30353045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0271-y
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料